ANUMIGILIMAB
UNII IA9ALH5N8D

Substance Identification & Data

This profile provides standardized clinical and technical data for Anumigilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IA9ALH5N8D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2416593-08-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IA9ALH5N8D

CAS Registry Number

2416593-08-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANUMIGILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184859

National Cancer Institute reference terminology for clinical and research data.

INN ID

11718

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-205

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anumigilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANUMIGILIMAB

Common Names & Synonyms

ANUMIGILIMAB [INN]

ANUMIGILIMAB [USAN]

ANUMIGILIMAB [WHO-DD]

IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR) (HUMAN MONOCLONAL CSL324 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CSL324 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CSF3R (COLONY STIMULATING FACTOR 3 RECEPTOR, CD114, COLONY STIMULATING FACTOR 3 RECEPTOR (GRANULOCYTE), GCSFR)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-445) (VH (HOMO SAPIENS IGHV3-23*01 (92.9%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (95.8%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-K1SV, GLYCOFORM ALFA

Technical Codes

CSL324

CSL-324

External Clinical & Regulatory Resources

Previous UNIIIA883WYU21

Next UNIIIAA753UT7B